Zacks Investment Research downgraded shares of American Vanguard Corporation (NYSE:AVD) from a buy rating to a hold rating in a research note published on Tuesday, August 8th.
According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “
Several other research analysts have also weighed in on the company. Roth Capital set a $22.00 target price on American Vanguard Corporation and gave the stock a buy rating in a research report on Tuesday, August 1st. BidaskClub lowered American Vanguard Corporation from a hold rating to a sell rating in a research report on Thursday, July 27th. Finally, TheStreet raised American Vanguard Corporation from a c+ rating to a b- rating in a research report on Friday, May 5th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. American Vanguard Corporation has a consensus rating of Hold and a consensus price target of $19.33.
American Vanguard Corporation (NYSE:AVD) last issued its earnings results on Monday, July 31st. The basic materials company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.01. American Vanguard Corporation had a return on equity of 5.10% and a net margin of 4.56%. The company had revenue of $77.90 million for the quarter, compared to analyst estimates of $77.71 million. During the same period in the prior year, the firm posted $0.11 EPS. The business’s revenue was up 7.2% compared to the same quarter last year. On average, equities analysts predict that American Vanguard Corporation will post $0.62 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.com-unik.info/2017/08/19/american-vanguard-corporation-nyseavd-stock-rating-lowered-by-zacks-investment-research-updated.html.
In other news, insider David` T. Johnson sold 6,000 shares of the company’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $19.00, for a total transaction of $114,000.00. Following the completion of the sale, the insider now owns 35,040 shares in the company, valued at approximately $665,760. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.70% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. Mason Street Advisors LLC increased its stake in American Vanguard Corporation by 7.0% in the first quarter. Mason Street Advisors LLC now owns 6,041 shares of the basic materials company’s stock valued at $100,000 after buying an additional 395 shares during the period. Acrospire Investment Management LLC increased its stake in American Vanguard Corporation by 83.7% in the second quarter. Acrospire Investment Management LLC now owns 8,685 shares of the basic materials company’s stock valued at $150,000 after buying an additional 3,956 shares during the period. BNP Paribas Arbitrage SA increased its stake in American Vanguard Corporation by 54.0% in the second quarter. BNP Paribas Arbitrage SA now owns 9,019 shares of the basic materials company’s stock valued at $156,000 after buying an additional 3,162 shares during the period. Louisiana State Employees Retirement System increased its stake in American Vanguard Corporation by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,500 shares of the basic materials company’s stock valued at $174,000 after buying an additional 100 shares during the period. Finally, Hancock Holding Co. bought a new stake in American Vanguard Corporation during the first quarter valued at about $186,000. Institutional investors own 77.75% of the company’s stock.
American Vanguard Corporation Company Profile
American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about American Vanguard Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for American Vanguard Corporation and related companies.